Pacira BioSciences News, Pacira BioSciences Quote, PCRX Quote

Pacira BioSciences (NQ:PCRX) Delayed: 26.25 +0.15 (0.57%)

Prev. Close

$26.10

Open

$25.98

52 Wk High

$80.25

52 Wk Low

$30.25

Day High

$26.34

Day Low

$25.91

P/E

N/A

EPS

$-2.08

Volume

427,538

Friends, Peers and Foes (?): BOLT (more...)

Apr 2, 2024 08:00 AM Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
Mar 13, 2024 07:04 AM Pacira BioSciences (PCRX) Granted Regenerative Medicine Advance Therapy Designation for PCRX-201
Mar 13, 2024 07:00 AM Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee
Mar 8, 2024 05:34 PM Form 4 Pacira BioSciences, Inc. For: Mar 06 Filed by: PACE GARY W
Mar 7, 2024 12:41 AM JPMorgan Assumes Pacira Pharmaceuticals (PCRX) at Overweight, 'Shares Well Positioned Ahead of Catalysts'
Mar 6, 2024 08:00 AM Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference
Mar 4, 2024 11:04 AM Pacira Pharmaceuticals (PCRX) PT Lowered to $36 at Jefferies
Mar 4, 2024 02:40 AM Pacira Pharmaceuticals (PCRX) PT Lowered to $40 at Barclays
Mar 1, 2024 07:26 AM Pacira Pharmaceuticals (PCRX) PT Lowered to $45 at RBC Capital
Feb 29, 2024 05:34 PM Form S-8 Pacira BioSciences, Inc.

Entities mentioned with PCRX